Zio XT ECG Monitoring System vs FibriCheck
AI Verdict
Choose Zio XT ECG Monitoring System if…
Choose Zio XT if you require continuous, high-fidelity ECG monitoring for up to 14 days to capture elusive arrhythmias and obtain a definitive diagnosis. Its wearable biosensor and FDA-cleared AI provide comprehensive data analysis and expert review, ideal for situations demanding a precise and extended cardiac overview where patient compliance and data integrity are paramount.
View Zio XT ECG Monitoring System →Choose FibriCheck if…
Choose FibriCheck if you need a convenient, on-demand solution for patients to regularly monitor their heart rhythm using their own smartphone. This app-based tool is excellent for frequent self-screening, managing known conditions, or providing immediate feedback on potential arrhythmias, especially when convenience and patient-initiated checks are prioritized over continuous, long-term ECG recording.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio XT ECG Monitoring System | FibriCheck |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware required. | Cloud-based (private cloud). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemZio XT offers a wearable, water-resistant biosensor with no external wires, designed for continuous monitoring up to 14 days with high patient compliance. FibriCheck, while convenient as a smartphone app, requires active patient engagement for measurements, making Zio XT more user-friendly for passive, long-term continuous diagnostic monitoring.
Clinical Value
Zio XT ECG Monitoring SystemZio XT provides continuous, single-lead ECG monitoring for up to 14 days, processed by FDA-cleared AI and expert review, offering a higher diagnostic yield for transient arrhythmias. FibriCheck uses smartphone camera-based PPG, which is suitable for intermittent screening but may not offer the same diagnostic depth or continuous data quality as a dedicated ECG device.
Pricing & Value
FibriCheckFibriCheck offers a more accessible pricing model with monthly subscriptions for end-users and lower costs for doctor-prescribed short-term monitoring. Zio XT has a higher per-patient cost, reflecting a more comprehensive diagnostic service involving a dedicated device and expert analysis. For individual patient self-monitoring and cost-effectiveness for basic screening, FibriCheck provides better value.
Enterprise Readiness
Zio XT ECG Monitoring SystemBoth tools are cloud-based, HIPAA compliant, and FDA cleared. Zio XT explicitly states 'has_baa: yes' and has established Medicare rates, indicating a robust framework for integration within healthcare enterprises. While FibriCheck implies BAA with HIPAA compliance and offers licensing agreements, Zio XT's explicit BAA and established reimbursement pathways suggest a more mature enterprise offering.
Innovation
Zio XT ECG Monitoring SystemZio XT demonstrates innovation through its comfortable, long-duration continuous ECG biosensor and proprietary deep-learned AI for high-fidelity data analysis. While FibriCheck innovates by leveraging ubiquitous smartphone technology for accessible heart rhythm monitoring, Zio XT's dedicated hardware and advanced AI for continuous, high-quality diagnostic data collection represent a more significant innovation in precise cardiac diagnostics.
Support & Docs
TieBoth iRhythm (Zio XT) and FibriCheck provide comprehensive support resources, including detailed user manuals, clinical reference guides, FAQs, and dedicated patient education materials. Both offer clear channels for customer support and documentation, making it difficult to distinguish a clear winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio XT ECG Monitoring System | FibriCheck |
|---|---|---|
| Name | Zio XT ECG Monitoring System | FibriCheck |
| Company | iRhythm Technologies | Qompium nv |
| Monitoring Method | Wearable single-lead ECG biosensor (Zio biosensor) | Smartphone camera-based PPG technology |
| Monitoring Duration | Up to 14 days | Not specified (subscription-based, with options for 7, 14, or 30 days when prescribed by a doctor) |
| Key Feature 1 | Continuous ambulatory cardiac monitoring for up to 14 days | AI-powered algorithm for arrhythmia detection and analysis |
| Key Feature 2 | Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis | Healthcare professional portal/dashboard for patient monitoring |
| Key Feature 3 | High patient compliance (up to 99%) and satisfaction | Detection of Atrial Fibrillation (AFib) and other arrhythmias |
Videos
Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and FibriCheck.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio XT ECG Monitoring System or FibriCheck
Backers
Who funded each tool's parent company.